• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Talia Technology chief steps down after 3 years

Article

Tampa, FL-Ted Newill, the president of Talia Technology Inc., is stepping down after 3 years at the helm.

Tampa, FL-Ted Newill, the president of Talia Technology Inc., is stepping down after 3 years at the helm.

Newill said he is leaving the company, effective July 30, for personal reasons. He led the 2004 Year of the Customer campaign and played a major role in the reorganization of the U.S. office. Talia Technology Inc. is the U.S. subsidiary of Talia Technology Ltd., which develops and sells the RTA for diagnosing glaucoma, diabetic retinopathy, age-related macular degeneration, and more.

While the company searches for a new president, Chief Executive Officer Dan Moran will manage operations.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.